Log In
BCIQ
Print this Print this
 

MuMo-1

  Manage Alerts
Collapse Summary General Information
Company Esteve S.A.
DescriptionTherapeutic targeting sigma-1 receptor
Molecular Target Sigma-1 receptor
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat pain
Regulatory Designation
PartnerMundipharma International Ltd.;
Purdue Pharma L.P.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$1,000.0M

0

$1,000.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/12/2015

$1,000.0M

0

$1,000.0M

Get a free BioCentury trial today